CORT
Corcept Therapeutics Incorporated · Healthcare
Chief Development Officer William Guyer sold $296K of Corcept Therapeutics Incorporated
Sold$296,346
$35.99Price
8,233Shares
−79%Stake
What CORT did after the filing
- The stock from Mon, Mar 9 open, $33.57
- +34.3%
- S&P 500, same days
- +5.7%
Measured over 30 trading days, to the Apr 21 close.
Traded Wed, Mar 4. Filed Fri, Mar 6, 4:30 PM ET, after the close. Returns use the Mar 9 open and the Apr 21 close. Not investment advice.